Sponsored By
Divestment written on a yellow sticky note on financial papers.png
MedicalBaxter to Shed Its Biopharma BusinessBaxter to Shed Its Biopharma Business
The divestiture is expected to fetch about $3.4 billion in net after-tax proceeds for Baxter.
Sign up for the PlasticsToday NewsFeed newsletter.